WCG Clinical

MAY 15, 2023

By harnessing patient insights on clinical research technology, data accuracy can be improved, the clinical trial process can be streamlined, and the burden on participants and sites can be reduced. Engaging with advocacy groups can also drive patient participation in trials.

Clinical Research 52

Clinical Research Development Trials Research 52

pharmaphorum

JUNE 8, 2021

It is also due to start a phase 3 trial in atopic dermatitis later this year. The investment deal covers net sales of tapinarof in all dermatological indications in the US, and the cash injection will fund both milestone payments to GSK as well as cover launch costs. billion product.

Sales 52

Sales Dermatology Licensing Licensing 52

pharmaphorum

OCTOBER 11, 2022

In a statement , PureTech said it had been required to go public with the talks once they started to be reported in the media to comply with UK financial regulations, but said this morning that they “were early in nature and the required announcement created the impression that discussions were more advanced than they were.”

Dermatology 52

Dermatology Clinical Trials Clinical Trials Regulation 52

Drug Discovery World

APRIL 16, 2023

DDW’s Megan Thomas rounds up highlights from Sunday 16 April at AACR 2023, from promising trial results for a personalised mRNA-based cancer vaccine to winners of lifetime achievement awards.

Clinical Trials 52

Clinical Trials Clinical Trials Research Vaccination 52

pharmaphorum

FEBRUARY 28, 2022

Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing application for Oleogel-S10, its drug for rare and debilitating skin disease epidermolysis bullosa (EB). pic.twitter.com/NzhGx1q1o8. — debra of America (@debraOfAmerica) February 28, 2022.

Drugs 96

Drugs Marketing Regulation FDA Approval 96

The Pharma Data

AUGUST 1, 2021

The approval by the Food and Drug Administration (FDA) was based on efficacy and safety data from the Saphnelo clinical development programme, including two TULIP Phase III trials and the MUSE Phase II trial. 12,13,14,15. 12,13,14,15. Saphnelo is under regulatory review for SLE in the EU and Japan.

Trials 52

Trials Clinical Development Antibody Dermatology 52

Delveinsight

AUGUST 25, 2021

They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . The Innovative Medicines Division focuses on Oncology, Immunology, Hepatology, Dermatology, Ophthalmology, Neuroscience, Cardiovascular, Renal and Metabolism, and Respiratory. trillion in 2021.

Vaccination 98

Vaccination Vaccine Sales Drugs 98

pharmaphorum

JANUARY 5, 2021

If they had also predicted that the second person to receive the vaccine out of trial would be a gentleman named William Shakespeare, they would certainly have been dismissed as a fantasist. “The real impact on submissions and approvals will be in 2021 and beyond, when the pandemic’s true impact on clinical trials becomes apparent”.

Sales 104

Sales Marketing Production Vaccination 104

The Pharma Data

JANUARY 26, 2021

Reddy’s”) and Global Response Aid FZCO (GRA) today announced the termination of Avigan Trial Study conducted in Kuwait focused on moderate to severe COVID patients in a hospital setting. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.

Life Science 40

Life Science Production Marketing Dermatology 40

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. Gained an EU label update to include data for axial manifestations of psoriatic arthritis (PsA), from the Ph3b MAXIMISE trial. Adakveo sales reached USD 37 million. Cosentyx. .

Sales 40

Sales Medicine Production Manufacturing 40

pharmaphorum

JULY 9, 2021

The company has also expanded the platform into similar inflammatory conditions in rheumatology, dermatology and oncology. Regulation barriers. Parkes says that most of the app’s functions were built based on patient insights. “We

Doctors 67

Doctors Doctor Marketing Development 67

The Pharma Data

DECEMBER 15, 2020

We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. Our Noble Purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”.

FDA Approval 52

FDA Approval Development Production Marketing 52

The Pharma Data

JUNE 18, 2021

1 Significantly more patients receiving risankizumab 360 mg achieved clinical remission (CDAI; U.S. analysis plan), with 52 percent on risankizumab 360 mg achieving clinical remission versus 41 percent in the induction-only control group (p<0.01). 1 Both patients continued in the trial. vice chairman and president, AbbVie.

Trials 40

Trials Development Clinical Trials Clinical Trials 40

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. Toujeo generated Sanofi €1.12

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

FEBRUARY 22, 2021

Key measures of efficacy include clinical remission (per Adapted Mayo Score), clinical response (per Adapted Mayo Score), endoscopic improvement and endoscopic response. More information on these trials can be found at www.clinicaltrials.gov (NCT03653026, NCT02819635, NCT03006068). About Upadacitinib (RINVOQ). Burmester G.R.,

Medicine 52

Medicine Development Drugs Trials 52